Institute for International Research

Lowest Registration Rates Now Available

Register by February 26 and Save $350 off the Standard Rates

Special Discounted Hotel Rate

Special Discounted Hotel Rate Available Until Monday, May 31, 2010.
To book your room, call 1-800-228-9290 and mention you are an IBC attendee at this event.

Keynotes Presentations

Design, Evolution and Applications of Repeat Proteins
Andreas Plückthun, University of Zurich

Antibody Combinations and Bispecific Antibodies Potently Neutralize Botulinum Neurotoxins
James D. Marks, University of California, San Francisco

Chemically Programmed Immunity: Antibodies and Vaccines
Carlos F. Barbas III, The Scripps Research Institute

Featured Presentations

Subvisible Aggregates and their Impact on Immunogenicity
Jack Ragheb, CDER, US FDA

Monoclonal Antibodies, Next Generation Antibodies, and Antibody Alternatives: An FDA Perspective
Ruth Cordoba-Rodriguez, CDER, US FDA

Analysis and Prediction of HLA Class II Restriced Response
Alessandro Sette, La Jolla Institute for Allergy and Immunology

Synthetic PDZ Domains
Sachdev S. Sidhu, University of Toronto

Rapid progress on the next generation of therapeutic proteins and novel scaffolds, as well as emerging new drug classes and biologics, is currently being made in preclinical and clinical programs. Featuring four conferences, IBC's Next Generation Protein Therapeutics Summit brings together leading companies and academics from different disciplines to cross-fertilize ideas, share new data, and discuss strategies that will help you turn promising molecules into products.

Event-at-a-Glance

IBC's 5th Annual Beyond Antibodies presents preclinical and clinical progress on multiple molecules, and highlights emerging companies like Bicycle Therapeutics, and Philogen so you can find novel approaches and lessons learned.
» Agenda | Download This Brochure

IBC's 4th Annual Protein Engineering & Design emphasizes strategies to improve drug-like properties of proteins to help you engineer more creative and robust molecules.
» Agenda | Download This Brochure

IBC's 1st Annual Immunogenicity of Biologics discusses multiple case studies from both antibody and alternative scaffold projects and presents preclinical and clinical strategies to mitigate immunogenicity that you can implement in your own lab.
» Agenda | Download This Brochure

IBC's 1st Annual Crossing the Barriers highlights novel approaches you can use to attack intracellular targets, find alternative protein delivery strategies and move your proteins and antibodies across the blood-brain-barrier and other membranes.
» Agenda | Download This Brochure